|Assessing for Risk, Benefit and Harm when Prescribing Opioids for Chronic Pain|
May 15, 2013
While long-term opioid therapy for chronic pain may benefit some patients, it may cause harm. A risk-benefit assessment should precede opioid prescriptions including evaluation for prescription opioid misuse risk, and assessing, discussing and documenting realistic treatment goals and risks. Patient-provider agreements and informed consents are important as are ongoing monitoring for benefit and harm using frequent face-to-face assessments, urine drug tests, pill counts and prescription drug monitoring program data.
Daniel P. Alford, MD, MPH, FACP, FASAM
The content of this activity does not relate to any product of a commercial interest.
The duration of this webinar is 60 minutes
|Add To Cart|